ZA966578B - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
ZA966578B
ZA966578B ZA9606578A ZA966578A ZA966578B ZA 966578 B ZA966578 B ZA 966578B ZA 9606578 A ZA9606578 A ZA 9606578A ZA 966578 A ZA966578 A ZA 966578A ZA 966578 B ZA966578 B ZA 966578B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
wounds
mannose
healing
promoting
Prior art date
Application number
ZA9606578A
Other languages
English (en)
Inventor
Mark William James Ferguson
Sally Freeman
Sarah Glenys Moore
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of ZA966578B publication Critical patent/ZA966578B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9606578A 1995-08-04 1996-08-02 Pharmaceutical composition. ZA966578B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516012.3A GB9516012D0 (en) 1995-08-04 1995-08-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA966578B true ZA966578B (en) 1998-02-02

Family

ID=10778773

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606578A ZA966578B (en) 1995-08-04 1996-08-02 Pharmaceutical composition.

Country Status (14)

Country Link
US (1) US6140307A (de)
EP (2) EP0841931B1 (de)
JP (2) JPH11510179A (de)
AT (2) ATE298579T1 (de)
AU (1) AU719992B2 (de)
CA (1) CA2229010C (de)
DE (2) DE69626987T2 (de)
DK (2) DK0841931T3 (de)
ES (2) ES2195000T3 (de)
GB (1) GB9516012D0 (de)
HK (1) HK1053264A1 (de)
PT (2) PT1291018E (de)
WO (1) WO1997005883A1 (de)
ZA (1) ZA966578B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB2316002B (en) * 1996-08-12 1998-09-23 British Tech Group Mannose-6-phosphate composition and its use in treating fibrotic disorders
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
AUPQ872300A0 (en) * 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
PL1628987T3 (pl) * 2003-05-20 2010-01-29 Pharmaxis Pty Ltd Związki mannozo-6-fosforanu do leczenia chorób zapalnych
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
WO2008144352A1 (en) 2007-05-17 2008-11-27 Sunny Biodiscovery, Inc. Threitol phosphates, salts thereof and methods of use
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
GB0910078D0 (en) 2009-06-11 2009-07-22 Renovo Ltd Uses of mannose-6-phosphate
GB0916334D0 (en) 2009-09-17 2009-10-28 Renovo Ltd Inhibition of tendon adhesions
GB0916332D0 (en) * 2009-09-17 2009-10-28 Renovo Ltd Medicaments
EP4356964A3 (de) 2018-08-10 2024-06-19 New York University Verwendung von igf-2-rezeptor-agonist-liganden zur behandlung von angelman-syndrom und autismus
US20210322451A1 (en) * 2018-08-10 2021-10-21 New York University Use of mannose 6 phosphate and modifications thereof for memory enhancement and reducing memory impairment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
WO1990001938A1 (en) * 1988-08-19 1990-03-08 The Australian National University Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
SE8904354D0 (sv) * 1989-12-21 1989-12-21 Matti Siren A pharmaceutical composition
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
DK129293D0 (da) * 1993-11-16 1993-11-16 Carlsberg Lab Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer

Also Published As

Publication number Publication date
CA2229010A1 (en) 1997-02-20
DE69634905T2 (de) 2006-04-27
EP1291018A1 (de) 2003-03-12
EP1291018B1 (de) 2005-06-29
ES2243657T3 (es) 2005-12-01
AU719992B2 (en) 2000-05-18
EP0841931A1 (de) 1998-05-20
HK1053264A1 (en) 2003-10-17
US6140307A (en) 2000-10-31
ATE235245T1 (de) 2003-04-15
PT1291018E (pt) 2005-08-31
DE69626987T2 (de) 2003-12-04
GB9516012D0 (en) 1995-10-04
AU6624896A (en) 1997-03-05
ES2195000T3 (es) 2003-12-01
JP2008239625A (ja) 2008-10-09
DE69634905D1 (de) 2005-08-04
CA2229010C (en) 2009-06-02
ATE298579T1 (de) 2005-07-15
EP0841931B1 (de) 2003-03-26
PT841931E (pt) 2003-06-30
DE69626987D1 (de) 2003-04-30
DK1291018T3 (da) 2005-09-12
DK0841931T3 (da) 2003-04-22
JPH11510179A (ja) 1999-09-07
WO1997005883A1 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
ZA966744B (en) Pharmaceutical composition.
EP1870103A3 (de) Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
CA2258895A1 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
GB9516012D0 (en) Pharmaceutical composition
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
EP1632248B8 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
GB9521608D0 (en) Pharmaceutical composition
NZ222434A (en) Tissue factor protein lacking its naturally associated phospholipid
ZA966953B (en) Pharmaceutical composition.
ZA966577B (en) Pharmaceutical composition.
AU1506692A (en) Pharmaceutical compositions
IL112469A0 (en) Composition for the treatment of an epidermal disorder
GB9413939D0 (en) Pharmaceutical composition for the treatment of chronic skin ulcers
FI956064A0 (fi) Menetelmä haavojen paranemisen edistämiseksi ja tähän soveltuvia koostumuksia
AUPP195398A0 (en) Pharmaceutical or veterinary composition for the treatment of skin disorders
AUPO882597A0 (en) Pharmaceutical composition for the treatment of skin disorders
IL119250A0 (en) Pharmaceutical composition for the treatment of syndrome X of reaven
IL119403A0 (en) Pharmaceutical composition for the treatment of syndrome X of reaven
IL116680A0 (en) Pharmaceutical composition for the treatment of depression
AUPM333594A0 (en) Pharmaceutical composition for the treatment of skin conditions
AU7341396A (en) Paclitaxel for the treatment of rheumatic diseases
IL106917A0 (en) Compositions for the treatment of skin disorders